Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
Marie‐Claude Bourgeois‐Daigneault(Centre Hospitalier de l’Université de Montréal), John C. Bell(Ottawa Hospital)
Cited by 84
Related Papers
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
|The Lancet Oncology|2008|522
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
|Nature Medicine|2015|167
Surgical Stress Promotes the Development of Cancer Metastases by a Coagulation-Dependent Mechanism Involving Natural Killer Cells in a Murine Model
|Annals of Surgery|2012|123
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
|Frontiers in Immunology|2023|13